News

STAT16h
Pharmalittle: We’re reading about Sarepta resisting FDA over Elevidys, agency naming top drug regulator, and more
Sarepta Therapeutics refused a FDA request to halt shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy ...
STAT6h
In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy
Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.
The Island1h
Red warning for strong winds and rough seas
Warning for strong winds and rough seas. Issued by the Natural Hazards Early Warning Centre  at 10.00 a.m. on 22 July 2025 ...